Langworthy D - Search Results

1

Probable chlorthalidone-induced hypokalemic rhabdomyolysis.

Singh G, Canton C, Langworthy D. Singh G, et al. Among authors: langworthy d. J Am Pharm Assoc (2003). 2024 Sep 13:102249. doi: 10.1016/j.japh.2024.102249. Online ahead of print. J Am Pharm Assoc (2003). 2024. PMID: 39278350

2

Agranulocytosis Associated With Use of Sulfamethoxazole/Trimethoprim in a Healthy Adult.

Bunch D, Brands C, Langworthy DR. Bunch D, et al. Among authors: langworthy dr. J Pharm Pract. 2024 Feb;37(1):229-233. doi: 10.1177/08971900221128854. Epub 2022 Sep 27. J Pharm Pract. 2024. PMID: 36165354

3

Early Diuresis After Colon and Rectal Surgery Does Not Reduce Length of Hospital Stay: Results of a Randomized Trial.

Danelich IM, Bergquist JR, Bergquist WJ, Osborn JL, Wright SS, Tefft BJ, Sturm AW, Langworthy DR, Mandrekar J, Devine RM, Kelley SR, Mathis KL, Pemberton JH, Jacob AK, Larson DW. Danelich IM, et al. Among authors: langworthy dr. Dis Colon Rectum. 2018 Oct;61(10):1187-1195. doi: 10.1097/DCR.0000000000001183. Dis Colon Rectum. 2018. PMID: 30192327 Clinical Trial.

4

Comparison of oral antibiotic failure rates in post-Roux-en-Y gastric bypass patients versus controls.

Roy DJ, Langworthy DR, Thurber KM, Lorentz PA, Dierkhising RA, Mundi MS. Roy DJ, et al. Among authors: langworthy dr. Surg Obes Relat Dis. 2017 Sep;13(9):1524-1529. doi: 10.1016/j.soard.2017.03.026. Epub 2017 Mar 29. Surg Obes Relat Dis. 2017. PMID: 28545917 Clinical Trial.

5

Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis.

Kaufman KR, Thurber KM, O'Meara JG, Langworthy DR, Kashiwagi DT. Kaufman KR, et al. Among authors: langworthy dr. J Clin Pharm Ther. 2016 Aug;41(4):409-13. doi: 10.1111/jcpt.12402. Epub 2016 May 19. J Clin Pharm Ther. 2016. PMID: 27193482

6

Clinical implications of statin therapy in patients undergoing hemodialysis.

Kim JJ, Langworthy DR, Hennessey EK. Kim JJ, et al. Among authors: langworthy dr. Am J Health Syst Pharm. 2014 May 1;71(9):703-10. doi: 10.2146/ajhp130305. Am J Health Syst Pharm. 2014. PMID: 24733132

7

Interaction forces between waterborne bacteria and activated carbon particles.

Busscher HJ, Dijkstra RJ, Langworthy DE, Collias DI, Bjorkquist DW, Mitchell MD, Van der Mei HC. Busscher HJ, et al. Among authors: langworthy de. J Colloid Interface Sci. 2008 Jun 1;322(1):351-7. doi: 10.1016/j.jcis.2008.03.018. Epub 2008 Mar 19. J Colloid Interface Sci. 2008. PMID: 18405910

8

Influence of adhesion to activated carbon particles on the viability of waterborne pathogenic bacteria under flow.

van der Mei HC, Atema-Smit J, Jager D, Langworthy DE, Collias DI, Mitchell MD, Busscher HJ. van der Mei HC, et al. Among authors: langworthy de. Biotechnol Bioeng. 2008 Jul 1;100(4):810-3. doi: 10.1002/bit.21820. Biotechnol Bioeng. 2008. PMID: 18351669

9

Adhesion and viability of waterborne pathogens on p-DADMAC coatings.

van der Mei HC, Rustema-Abbing M, Langworthy DE, Collias DI, Mitchell MD, Bjorkquist DW, Busscher HJ. van der Mei HC, et al. Among authors: langworthy de. Biotechnol Bioeng. 2008 Jan 1;99(1):165-9. doi: 10.1002/bit.21538. Biotechnol Bioeng. 2008. PMID: 17570712

10

Removal of two waterborne pathogenic bacterial strains by activated carbon particles prior to and after charge modification.

Busscher HJ, Dijkstra RJ, Engels E, Langworthy DE, Collias DI, Bjorkquist DW, Mitchell MD, Van der Mei HC. Busscher HJ, et al. Among authors: langworthy de. Environ Sci Technol. 2006 Nov 1;40(21):6799-804. doi: 10.1021/es061282r. Environ Sci Technol. 2006. PMID: 17144313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters